Efficacy of a Persian Herbal Medicine Compound on Coronavirus Disease 2019 (COVID-19): A Randomized Clinical Trial

Overview

Journal Integr Med Res

Publisher Elsevier

Specialty Rehabilitation Medicine

Date 2022 Jul 5

PMID 35783542

Authors

Mohammad Setayesh

Mehrdad Karimi

Arman Zargaran

Hamid Abousaidi

Armita Shahesmaeili

Fatemeh Amiri

Fatemeh Sadat Hasheminasab

Affiliations

Soon will be listed here.

Abstract

Background: The global attention to the capacities of traditional medicine for alleviating the clinical manifestations of COVID-19 has been growing. The present trial aimed to evaluate the efficacy and safety of a Persian herbal medicine formula among patients with COVID-19.

Methods: The present trial was conducted in Afzalipour hospital, Kerman, Iran, from June to September 2020. Hospitalized COVID-19 patients were randomly divided into intervention (Persian herbal medicine formula + routine treatment) or control (only routine treatment) groups. The intervention group received both capsule number 1 and 2 every 8 hours for 7 days. Capsule number 1 contained extract of the , and , and the second capsule was filled by powder. Participants were followed up to 7 days. The primary outcome was the number of hospitalization days, while cough, fever, and respiratory rate, days on oxygen (O) therapy, and mortality rate were considered as the secondary outcomes.

Results: Eighty-two patients were enrolled to the study, while 79 cases completed the trial and their data were analyzed (mean age: 59.1 ± 17.1 years). Based on the results, the Persian medicine formula decreased the mean hospitalization days, so that the mean difference of length of hospitalization as primary outcome was 2.95 ± 0.43 days. A significant clinical improvement was observed regarding dyspnea, need for O) therapy, and respiratory rate in the intervention group. No adverse effects were reported.

Conclusion: The present study supported the use of the Persian medicine formula as an adjuvant therapy for hospitalized COVID-19 patients. Study registration: Iranian Registry of Clinical Trials (www.irct.ir): IRCT20200330046899N1.

Study Registration: Iranian Registry of Clinical Trials (www.irct.ir): IRCT20200330046899N1.

Citing Articles

for the treatment of COVID-19 patients: A rapid systematic review and meta-analysis of randomized controlled trials.

Umer M, Naveed A, Maryam Q, Ahmad Cheema H, Shahid A, Hermis A Food Sci Nutr. 2024; 12(3):2061-2067.

PMID: 38455176 PMC: 10916652. DOI: 10.1002/fsn3.3906.

: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics.

Tang S, Wang M, Peng Y, Liang Y, Lei J, Tao Q Front Pharmacol. 2024; 15:1290888.

PMID: 38323080 PMC: 10844384. DOI: 10.3389/fphar.2024.1290888.

Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects.

Cyril A, Ali N, Nelliyulla Parambath A, Vazhappilly C, Jan R, Karuvantevida N Inflammopharmacology. 2023; 32(1):273-285.

PMID: 37966624 DOI: 10.1007/s10787-023-01385-9.

The effect of crocin-selenium nanoparticles on the cognition and oxidative stress markers of multiple sclerosis patients: a randomized triple-blinded placebo-controlled clinical trial.

Rezaeimanesh N, Rafiee P, Saeedi R, Khosravian P, Sahraian M, Eskandarieh S Biometals. 2023; 37(2):305-319.

PMID: 37917350 DOI: 10.1007/s10534-023-00548-z.

Editorial: Treatment of animal diseases with veterinary phytotherapy.

Nabi F, Shi D, Wu Q, Baloch D Front Vet Sci. 2023; 10:1171987.

PMID: 37089408 PMC: 10117879. DOI: 10.3389/fvets.2023.1171987.

References

Molavi Vardanjani H, Heydari S, Dowran B, Pasalar M . A cross-sectional study of Persian medicine and the COVID-19 pandemic in Iran: Rumors and recommendations. Integr Med Res. 2020; 9(3):100482. PMC: 7375960. DOI: 10.1016/j.imr.2020.100482. View

Lin J . Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 2003; 59(1):41-7. DOI: 10.1016/s0166-3542(03)00030-5. View

BenSaad L, Kim K, Quah C, Kim W, Shahimi M . Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement Altern Med. 2017; 17(1):47. PMC: 5237561. DOI: 10.1186/s12906-017-1555-0. View

Soleymani S, Zargaran A . A Historical Report on Preparing Sustained Release Dosage Forms for Addicts in Medieval Persia, 16th Century AD. Subst Use Misuse. 2018; 53(10):1726-1729. DOI: 10.1080/10826084.2018.1432648. View

Koshak D, Koshak P . L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies. Curr Ther Res Clin Exp. 2020; 93:100602. PMC: 7445151. DOI: 10.1016/j.curtheres.2020.100602. View

Frattaruolo L, Carullo G, Brindisi M, Mazzotta S, Bellissimo L, Rago V . Antioxidant and Anti-Inflammatory Activities of Flavanones from L. (licorice) Leaf Phytocomplexes: Identification of Licoflavanone as a Modulator of NF-kB/MAPK Pathway. Antioxidants (Basel). 2019; 8(6). PMC: 6616548. DOI: 10.3390/antiox8060186. View

Song Y, Li X, Wu Y, Shen Y, Liu F, Gao P . Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model. Acta Pharmacol Sin. 2018; 39(8):1317-1325. PMC: 6289379. DOI: 10.1038/aps.2017.147. View

Miyake K, Tango T, Ota Y, Mitamura K, Yoshiba M, Kako M . Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis. J Gastroenterol Hepatol. 2002; 17(11):1198-204. DOI: 10.1046/j.1440-1746.2002.02876.x. View

Khan M, Afzal M . Chemical composition of Nigella sativa Linn: Part 2 Recent advances. Inflammopharmacology. 2016; 24(2-3):67-79. PMC: 4883276. DOI: 10.1007/s10787-016-0262-7. View

10.

Sultan M, Butt M, Qayyum M, Suleria H . Immunity: plants as effective mediators. Crit Rev Food Sci Nutr. 2014; 54(10):1298-308. DOI: 10.1080/10408398.2011.633249. View

11.

Zhang R, Qiu H, Wang N, Long F, Mao D . Effect of Rheum palmatum L. on NF-κB signaling pathway of mice with acute liver failure. Asian Pac J Trop Med. 2015; 8(10):841-7. DOI: 10.1016/j.apjtm.2015.09.011. View

12.

Pal M, Berhanu G, Desalegn C, Kandi V . Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020; 12(3):e7423. PMC: 7182166. DOI: 10.7759/cureus.7423. View

13.

Sabouri Ghannad M, Mohammadi A, Safiallahy S, Faradmal J, Azizi M, Ahmadvand Z . The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1. Jundishapur J Microbiol. 2014; 7(7):e11616. PMC: 4216581. DOI: 10.5812/jjm.11616. View

14.

Guarner J . Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol. 2020; 153(4):420-421. PMC: 7109697. DOI: 10.1093/ajcp/aqaa029. View

15.

Marsik P, Kokoska L, Landa P, Nepovim A, Soudek P, Vanek T . In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med. 2005; 71(8):739-42. DOI: 10.1055/s-2005-871288. View

16.

Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J . Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020; 158:104896. PMC: 7211759. DOI: 10.1016/j.phrs.2020.104896. View

17.

Forouzanfar F, Bazzaz B, Hosseinzadeh H . Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci. 2015; 17(12):929-38. PMC: 4387228. View

18.

Haidari M, Ali M, Ward Casscells 3rd S, Madjid M . Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine. 2009; 16(12):1127-36. DOI: 10.1016/j.phymed.2009.06.002. View

19.

Franceschelli S, Pesce M, Vinciguerra I, Ferrone A, Riccioni G, Patruno A . Licocalchone-C extracted from Glycyrrhiza glabra inhibits lipopolysaccharide-interferon-γ inflammation by improving antioxidant conditions and regulating inducible nitric oxide synthase expression. Molecules. 2011; 16(7):5720-34. PMC: 6264366. DOI: 10.3390/molecules16075720. View

20.

Hashempur M, Hashempour M, Mosavat S, Heydari M . Rhazes-His Life and Contributions to the Field of Dermatology. JAMA Dermatol. 2017; 153(1):70. DOI: 10.1001/jamadermatol.2016.0144. View